Abrams Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Abrams Capital Management’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-9,108,867	Closed	-$31M	–	22
2018 Q3	$31M	Sell	9,108,867 -841,188	-8%	-$3.03M	0.82%	19
2018 Q2	$37.4M	Buy	9,950,055 +230,879	+2%	+$1.12M	1.04%	18
2018 Q1	$39.8M	Hold	9,719,176	–	–	1.25%	17
2017 Q4	$45.2M	Buy	9,719,176 +4,000,000	+70%	+$22M	1.52%	16
2017 Q3	$40.6M	Hold	5,719,176	–	–	1.58%	14
2017 Q2	$41.4M	Hold	5,719,176	–	–	1.64%	15
2017 Q1	$35.2M	Hold	5,719,176	–	–	1.35%	15
2016 Q4	$33.5M	Hold	5,719,176	–	–	1.23%	16
2016 Q3	$30.4M	Hold	5,719,176	–	–	1.51%	15
2016 Q2	$37.9M	Hold	5,719,176	–	–	1.98%	11
2016 Q1	$26.7M	Buy	5,719,176 +219,176	+4%	+$875K	1.26%	16
2015 Q4	$27.8M	Buy	5,500,000 +500,000	+10%	+$2.38M	1.52%	15
2015 Q3	$17.6M	Buy	+5,000,000	New	+$33.5M	1.26%	14

Abrams Capital Management's KERX Position: Q4 2018 in Review

Abrams Capital Management sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 9,108,867 shares — an estimated $31M sold.

Abrams Capital Management first reported a position in KERX in Q3 2015 and held it in 13 quarters. The position peaked at $45.2M in Q4 2017. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

Abrams Capital Management reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
Abrams Capital Management sold 9,108,867 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $31M.
Abrams Capital Management first reported a position in Keryx Biopharmaceuticals Inc in Q3 2015 and held it in 13 quarters.
Abrams Capital Management's Keryx Biopharmaceuticals Inc position peaked at $45.2M in Q4 2017.
1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Abrams Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.